European Mid-Caps

Top European Pharma Mid-Cap Ranking 2019

The European MidPharma Performance Ranking 2019 is taken from The Novasecta European Midpharma Report 2019, which examines how European mid-cap pharma companies are surviving and thriving. With scores assigned to R&D investment, commercial revenues and business development, this is a comprehensive list of the recent performance of some of Europe’s leading mid-caps. 

The European MidPharma Performance Ranking 2019 is taken from The Novasecta European Midpharma Report 2019, which examines how European mid-cap pharma companies are surviving and thriving. With scores assigned to R&D investment, commercial revenues and business development, this is a comprehensive list of the recent performance of some of Europe’s leading mid-caps. 

Written by Louis Haynes on 05.06.2019
Written by Louis Haynes on 05.06.2019

SHARE

Share on twitter
Share on linkedin

5 Top European Mid-Cap CEOs to Know

10.05.2019

Bringing together insights from the heads of some of Europe’s most prominent mid-cap pharma firms. The leaders of Ipsen, Genmab, Pierre Fabre, Esteve and Servier outline the strategic directions in which their companies are turning and how they are planning to ensure a successful future…

Swiss Mid-Caps and Minnows: At the Vanguard of Creativity

05.06.2019

In view of the manifold hurdles encountered when attempting to raise capital, Switzerland’s medium capitalized entities and SMEs have grown adept at punching well above their weight. After the giants, Roche and Novartis, some of the larger companies in the Swiss pharma sector like Ferring and IBSA are privately held, and some have developed…

European MidPharmas: Focused and Resilient, yet Vulnerable

11.06.2019

European MidPharmas – R&D based pharmaceutical companies with annual revenues of between EUR 50 million and 5 billion – are having to be increasingly focused and resilient to succeed and fend off their inherent vulnerabilities according to a new report from specialist pharma and biotech consultancy Novasecta….

ABOUT

SOCIAL MEDIA

For media inquiries, please contact: media@pharmaboardroom.com

Subscribe